C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 21/00 (2006.01) C12Q 1/68 (2006.01) G01N 33/574 (2006.01) G06F 17/30 (2006.01) G06F 19/00 (2006.01)
Patent
CA 2450004
The examination of mutations in the mitochondrial genome is used as a diagnostic system for diseases such as pxostate cancer, and non melanoma skin cancer. Characteristic mutations and rearrangements including, paint mutations (transitions, transversions), deletions, inversions, duplications, recombinations, insertions or combinations thereof in the mitochondrial genome are used as early indicators of prostate cancer, and non melanoma skin cancer. Moreover, the 4977 bp, or "common deletion" as well as other associated mutations and/or deletions are used as a measure of aging.
Birch-Machin Mark
Dakubo Gabriel D.
Ngom Alioune
Parr Ryan
Th'ng John
1304854 Ontario Ltd.
Blake Cassels & Graydon Llp
Genesis Genomics Inc.
LandOfFree
Complete mitochondrial genome sequences as a diagnostic tool... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Complete mitochondrial genome sequences as a diagnostic tool..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Complete mitochondrial genome sequences as a diagnostic tool... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1700344